An Open-Label, Multicenter, Randomized, Phase 3 Study of S-1 and Cisplatin Compared with 5-FU and Cisplatin in Patients with Metastatic Diffuse Gastric Cancer Previously Untreated with Chemotherapy (TPU-S1303)
Phase of Trial: Phase III
Latest Information Update: 12 Sep 2017
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Cisplatin; Fluorouracil
- Indications Gastric cancer; Oesophageal cancer
- Focus Registrational; Therapeutic Use
- Acronyms DIGEST
- Sponsors Taiho Pharmaceutical
- 12 Sep 2017 Results of identification of patient population with longer survival by using clinical covariate model data from FLAGS and DIGEST phase III trials presented at the 42nd European Society for Medical Oncology Congress
- 01 Sep 2017 According to results published in the Annals of Oncology, the trial terminated early due to slow patient accrual and the primary end point (overall survival) was not met.
- 01 Sep 2017 Status changed from active, no longer recruiting to discontinued, according to results published in the Annals of Oncology.